e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Host–microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease
Reinoud Gosens, Pieter S. Hiemstra, Ian M. Adcock, Ken R. Bracke, Robert P. Dickson, Philip M. Hansbro, Susanne Krauss-Etschmann, Hermelijn H. Smits, Frank R.M. Stassen, Sabine Bartel
Source:
Eur Respir J, 56 (2) 1902320; 10.1183/13993003.02320-2019
Journal Issue:
August
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Reinoud Gosens, Pieter S. Hiemstra, Ian M. Adcock, Ken R. Bracke, Robert P. Dickson, Philip M. Hansbro, Susanne Krauss-Etschmann, Hermelijn H. Smits, Frank R.M. Stassen, Sabine Bartel. Host–microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease. Eur Respir J, 56 (2) 1902320; 10.1183/13993003.02320-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Emerging classes of drugs for the treatment of obstructive lung disease
European Respiratory Society guideline on long term management of children with bronchopulmonary dysplasia
Related content which might interest you:
The lung microbiome in obstructive airways disease: potential pathogenetic roles
Source: Eur Respir Monogr 2019; 83: 140-157
Year: 2019
Cellular interactions in the pathogenesis of interstitial lung diseases
Source: Eur Respir Rev 2015; 24: 102-114
Year: 2015
Determinants of lung cancer evolution: immune escape and inflammation
Source: International Congress 2018 – Scientific Year in Review
Year: 2018
Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities
Source: Eur Respir J 2014; 44: 513-522
Year: 2014
Human rhinovirus 16 infection of human macrophages significantly impairs their phagocytic and regulatory functions: implications in understanding chronic inflammatory lung disease
Source: International Congress 2017 – New Mechanistic Findings in COPD
Year: 2017
The environment, epigenetics and lung disease
Source: Annual Congress 2013 –PG6 Epigenetics of asthma and COPD
Year: 2013
The consequences of microbiome and pathogen dynamics for chronic lung diseases
Source: Annual Congress 2012 - The bacterial microbiota: implications for health and disease - joint session with the World Allergy Organisation
Year: 2012
Cellular mechanisms of paediatric lung disease
Source: Virtual Congress 2020 – Paediatric year in review
Year: 2020
Interplay between bacterial infections, hypoxia and the development of chronic lung diseases
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009
Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy
Source: Eur Respir Rev, 31 (163) 210241; 10.1183/16000617.0241-2021
Year: 2022
Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure
Source: Eur Respir Rev, 30 (162) 210077; 10.1183/16000617.0077-2021
Year: 2021
Host–microbe interactions in distal airways: relevance to chronic airway diseases
Source: Eur Respir Rev 2015; 24: 78-91
Year: 2015
Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009
Crosstalk between lung fibroblasts and T-lymphocytes: Implications for anti-viral responses in chronic lung disease
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
Angiogenesis in lung development, injury and repair: implications for chronic lung disease of prematurity
Source: Annual Congress 2008 - Physiological year in review
Year: 2008
Influenza virus-induced lung injury: pathogenesis and implications for treatment
Source: Eur Respir J 2015; 45: 1463-1478
Year: 2015
Host-microbe interactions: implications for protective immunity in the lung
Source: Lung Science Conference 2015
Year: 2015
Signalling and transcriptional regulation in inflammatory and immune cells: importance in lung biology and disease
Source: Eur Respir J 2005; 26: 762-763
Year: 2005
Current concepts: host–pathogen interactions in cystic fibrosis airways disease
Source: Eur Respir Rev 2014; 23: 320-332
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept